Loading...
BB Biotech AG
BION.SW•SIX
HealthcareBiotechnology
CHF30.85
CHF0.15(0.49%)
BB Biotech AG (BION.SW) Financial Performance & Statements
Review BB Biotech AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
155.94%
↑ 155.94%
Operating Income Growth
382.01%
↑ 382.01%
Net Income Growth
136.74%
↑ 136.74%
Operating Cash Flow Growth
39.53%
↑ 39.53%
Operating Margin
157.21%
↑ 157.21%
Gross Margin
188.70%
↑ 188.70%
Net Profit Margin
75.60%
↑ 75.60%
ROE
3.24%
↑ 3.24%
ROIC
6.90%
↑ 6.90%
BB Biotech AG (BION.SW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for BB Biotech AG stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $67.14M | -$149.69M | -$79.33M | $262.27M |
| Cost of Revenue | $0.00 | -$1.24M | -$79.36M | -$8.44M |
| Gross Profit | $67.14M | -$148.45M | $32000.00 | $270.71M |
| Gross Profit Ratio | $1.00 | $0.99 | -$0.00 | $1.03 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.43M | $7.46M | $7.73M | $1.68M |
| Operating Expenses | $6.43M | -$149.69M | $7.73M | $1.75M |
| Total Costs & Expenses | $6.43M | $6.57M | $85.53M | $8.76M |
| Interest Income | $0.00 | $0.00 | $32000.00 | $1.44M |
| Interest Expense | $0.00 | $1.20M | $1.57M | $1.44M |
| Depreciation & Amortization | -$59.78M | $0.00 | $7.70M | -$261.96M |
| EBITDA | $0.00 | $0.00 | -$78.73M | -$77.80M |
| EBITDA Ratio | $0.00 | $0.00 | $0.99 | -$0.30 |
| Operating Income | $60.70M | -$157.15M | -$7.70M | $261.96M |
| Operating Income Ratio | $0.90 | $1.05 | $0.10 | $1.00 |
| Other Income/Expenses (Net) | -$1.05M | $0.00 | -$79.36M | $75.13M |
| Income Before Tax | $59.65M | -$157.15M | -$87.06M | $260.51M |
| Income Before Tax Ratio | $0.89 | $1.05 | $1.10 | $0.99 |
| Income Tax Expense | $3000.00 | $19000.00 | $19000.00 | $19000.00 |
| Net Income | $59.66M | -$157.17M | -$87.08M | $260.49M |
| Net Income Ratio | $0.89 | $1.05 | $1.10 | $0.99 |
| EPS | $1.08 | -$2.87 | -$1.60 | $4.75 |
| Diluted EPS | $1.09 | -$2.87 | -$1.60 | $4.75 |
| Weighted Avg Shares Outstanding | $55.21M | $54.76M | $54.43M | $54.85M |
| Weighted Avg Shares Outstanding (Diluted) | $54.80M | $54.76M | $54.43M | $54.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan